sn.at – Date: 01.06.2024Author: Iris Burtscher, sn.at – Source
Time to Read: 7 minutes
sn.at – Date: 01.06.2024
Author: Iris Burtscher, sn.at – Source
After a year of focusing on PCR tests during the pandemic, Novogenia is returning to its core business of genetic analysis and personalized supplements. The company, which became a major player in PCR testing, has now completed its last COVID-19 test. Moving forward, Novogenia is investing heavily in expanding its genetic analysis services and personalized product offerings.
We do not sell our products directly to end customers, but we would be pleased to hear from you so that we can recommend a suitable partner in your are.
That genes affect body weight, the effectiveness of certain weight loss strategies, and the ability to deal with certain nutrients is supported by multiple scientific studies for each gene. Therefore, the genetic traits determined by this analysis are considered scientifically confirmed.
The adaptations of micronutrient dosing or dietary recommendations derived from these scientific findings require the so-called gold standard for clear scientific proof – these are randomised, placebo-controlled studies. These already exist for folic acid and vitamin B2 but have not yet been published for all genetic effects in this programme. For this reason, the genetic adaptation of micronutrient dosing and food evaluation should be considered logical conclusions and not scientifically proven. Your optional supplements are thus scientifically tailored to your lifestyle, your blood values, and additionally experimentally to your genes – depending on your choice
of analyses.
© 2024 Novogenia Marketing GmbH. All Rights Reserved.
